Despite the emerging global challenges of 2020, CHIL participated in Medlab Middle East in Dubai, from February 3 to 6, demonstrating resilience and commitment to the diagnostics community. The event provided an opportunity to maintain engagement with regional stakeholders, share insights on innovative diagnostic approaches, and explore collaborative opportunities even under unprecedented circumstances.
You may also like
2 months ago
Strategic Technology Transfer
A long-term production and technology transfer agreement with Brazil was signed, reinforcing CHIL’s commitment to sustainable global manufacturing partnerships.
2 years ago
Innovation and Intellectual Property
CHIL initiated patent applications and product development efforts focused on the detection of breast cancer and breast anomalies, signaling a strategic move toward advanced diagnostic technologies.